3-Bromo-5,7-dichloro-1H-pyrazolo[4,3-d]pyrimidine

Catalog No. :
ACZQRB853
CAS No. :
1934543-12-0
Molecular Formula :
C5HBrCl2N4
Molecular Weight :
267.90

IUPAC Name:3-bromo-5,7-dichloro-1H-pyrazolo[4,3-d]pyrimidine

3-Bromo-5,7-dichloro-1H-pyrazolo[4,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$111.00Login to see priceIn stockInquiry
100mg95%$134.00Login to see priceIn stockIn stock
250mg95%$236.00Login to see priceIn stockIn stock
1g95%$942.00Login to see priceIn stockInquiry
5g95%$4569.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5,7-dichloro-1H-pyrazolo[4,3-d]pyrimidine
IUPAC Name3-bromo-5,7-dichloro-1H-pyrazolo[4,3-d]pyrimidine
MDL No.MFCD29761463
Molecular FormulaC5HBrCl2N4
Molecular Weight267.90
SMILESClC1N=C(Cl)N=C2C(Br)=NNC=12
InChI KeyIUVXUHIFNUFWDT-UHFFFAOYSA-N
Synonym3-bromo-5,7-dichloro-1H-pyrazolo[4,3-d]pyrimidine;1H-Pyrazolo[4,3-d]pyrimidine, 3-bromo-5,7-dichloro-;3-bromo-5,7-dichloro-2H-pyrazolo[4,3-d]pyrimidine
CAS No.1934543-12-0
PubChem CID92133846

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZQRB853 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZQRB853 route product structure diagram
    ACZQRB8531934543-12-0 In Stock
Inquiry

2. ACZQRB853 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWDOM794 route compound structure diagram
    ACWDOM7941196157-42-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZQRB853 route product structure diagram
    ACZQRB8531934543-12-0 In Stock
Inquiry

Comments (0)